发明名称 Rna respiratory syncytial virus vaccines
摘要 A vector comprising a first DNA sequence which is complementary to at least part of an alphavirus RNA genome and having the complement of complete alphavirus DNA genome replication regions, a second DNA sequence encoding a paramyxovirus protein, particularly a respiratory syncytial virus fusion (RSV F) protein or a RSV F protein fragment that generates antibodies that specifically react with RSV F protein, the first and second DNA sequences being under the transcriptional control of a promoter is described. Such vector may be used to produce an RNA transcript which may be used to immunize a host, including a human host, to protect the host against disease caused by paramyxovirus, particularly respiratory syncytial virus, by administration to the host. The RNA transcript may be formed by linearization of the vector through cleavage at a unique restriction site in a plasmid vector and then transcribing the linear molecule.
申请公布号 AU9056998(A) 申请公布日期 1999.03.22
申请号 AU19980090569 申请日期 1998.09.03
申请人 CONNAUGHT LABORATORIES LIMITED 发明人 MARK PARRINGTON
分类号 C12N15/09;A61K31/7105;A61K39/155;A61P31/12;A61P31/14;C07K14/115;C07K14/135;C12N5/10;C12N15/45;C12N15/86 主分类号 C12N15/09
代理机构 代理人
主权项
地址